The 2024 Jiangsu Pharmaceutical Association Science and Technology Award ceremony was held in Nanjing on November 22. Professor Shen Song's research team from the School of Pharmacy at Jiangsu University won the first prize for their project "Exogenous Trigger-Based Intelligent Drug Delivery Therapy System". The project's lead researchers include Professor Shen Song, Associate Professor Cao Jin, Chief Pharmacist Wu Lin, and Associate Professor Qi Xueyong.
This project focuses on the cutting-edge field of intelligent drug delivery systems, addressing key scientific challenges in traditional drug delivery methods such as poor targeting, uncontrolled release, and significant toxic side effects. It innovatively proposes an intelligent response-based drug delivery strategy triggered by exogenous stimuli (e.g., physical signals like light, magnetism, or heat, or specific chemical microenvironments). The team designed and constructed a series of novel intelligent nanodrug delivery vehicles, achieving controlled and precise drug release at the lesion site. This significantly improved drug utilization and therapeutic efficacy while reducing systemic toxic side effects. The research findings demonstrate substantial application potential and broad clinical translation prospects in the treatment of major diseases such as tumors and inflammatory disorders.
The Jiangsu Pharmaceutical Association Science and Technology Award, a prestigious accolade in the province's pharmaceutical field, honors outstanding scientific achievements that have made groundbreaking advancements in fundamental research, applied studies, and technological development, yielding significant socioeconomic benefits. This recognition underscores Professor Shen Song's team's innovative contributions to intelligent drug delivery. The honor not only demonstrates our institute's robust capabilities in cutting-edge pharmaceutical research and innovation but also inspires researchers to pursue excellence and scale new heights, contributing more "Jiangda Wisdom" and "Pharmaceutical Garden Power" to propel pharmaceutical progress and the high-quality development of the biopharmaceutical industry.
